Matches in SemOpenAlex for { <https://semopenalex.org/work/W4205697008> ?p ?o ?g. }
- W4205697008 endingPage "1497" @default.
- W4205697008 startingPage "1491" @default.
- W4205697008 abstract "At an international online expert meeting held on September 16, 2021, the results of the empagliflozin research program EMPA-REG Outcome, EMPEROR-Reduced and EMPEROR-Preserved were reviewed. We analyzed cardiovascular and renal outcomes during the treatment with empagliflozin in patients with chronic heart failure, regardless of the presence of type 2 diabetes mellitus. The positive results of the EMPEROR-Preserved study are updated and their significance for clinical practice is discussed. Several proposals have been adopted that will accelerate the introduction of empagliflozin therapy into practice in patients with heart failure and overcome clinical inertia." @default.
- W4205697008 created "2022-01-26" @default.
- W4205697008 creator A5005956916 @default.
- W4205697008 creator A5009259313 @default.
- W4205697008 creator A5015696627 @default.
- W4205697008 creator A5019124562 @default.
- W4205697008 creator A5022345225 @default.
- W4205697008 creator A5025453921 @default.
- W4205697008 creator A5027612655 @default.
- W4205697008 creator A5032927181 @default.
- W4205697008 creator A5036074880 @default.
- W4205697008 creator A5037009065 @default.
- W4205697008 creator A5043862869 @default.
- W4205697008 creator A5043877274 @default.
- W4205697008 creator A5045482135 @default.
- W4205697008 creator A5045557788 @default.
- W4205697008 creator A5049778403 @default.
- W4205697008 creator A5051165361 @default.
- W4205697008 creator A5053619220 @default.
- W4205697008 creator A5056005213 @default.
- W4205697008 creator A5056277307 @default.
- W4205697008 creator A5064965402 @default.
- W4205697008 creator A5073778883 @default.
- W4205697008 creator A5075358751 @default.
- W4205697008 creator A5088674785 @default.
- W4205697008 date "2021-12-15" @default.
- W4205697008 modified "2023-10-14" @default.
- W4205697008 title "Empagliflozin and heart failure: position paper of the experts on the results of the online meeting and discussion of the EMPEROR-Preserved Trial" @default.
- W4205697008 cites W2081005181 @default.
- W4205697008 cites W2085453834 @default.
- W4205697008 cites W2090544953 @default.
- W4205697008 cites W2146264128 @default.
- W4205697008 cites W2152413054 @default.
- W4205697008 cites W2273304042 @default.
- W4205697008 cites W2416483093 @default.
- W4205697008 cites W2465014439 @default.
- W4205697008 cites W2514728381 @default.
- W4205697008 cites W2611066427 @default.
- W4205697008 cites W2612667451 @default.
- W4205697008 cites W2758197294 @default.
- W4205697008 cites W2769309750 @default.
- W4205697008 cites W2801748041 @default.
- W4205697008 cites W2841694452 @default.
- W4205697008 cites W2883756867 @default.
- W4205697008 cites W2907791107 @default.
- W4205697008 cites W2919920736 @default.
- W4205697008 cites W2958440246 @default.
- W4205697008 cites W3024005808 @default.
- W4205697008 cites W3043378534 @default.
- W4205697008 cites W3044509953 @default.
- W4205697008 cites W3080857839 @default.
- W4205697008 cites W3081830235 @default.
- W4205697008 cites W3093773039 @default.
- W4205697008 cites W3110894831 @default.
- W4205697008 cites W3115836333 @default.
- W4205697008 cites W3158049170 @default.
- W4205697008 cites W3173612561 @default.
- W4205697008 cites W3193297191 @default.
- W4205697008 cites W3193598686 @default.
- W4205697008 doi "https://doi.org/10.26442/00403660.2021.12.201281" @default.
- W4205697008 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36286678" @default.
- W4205697008 hasPublicationYear "2021" @default.
- W4205697008 type Work @default.
- W4205697008 citedByCount "6" @default.
- W4205697008 countsByYear W42056970082022 @default.
- W4205697008 countsByYear W42056970082023 @default.
- W4205697008 crossrefType "journal-article" @default.
- W4205697008 hasAuthorship W4205697008A5005956916 @default.
- W4205697008 hasAuthorship W4205697008A5009259313 @default.
- W4205697008 hasAuthorship W4205697008A5015696627 @default.
- W4205697008 hasAuthorship W4205697008A5019124562 @default.
- W4205697008 hasAuthorship W4205697008A5022345225 @default.
- W4205697008 hasAuthorship W4205697008A5025453921 @default.
- W4205697008 hasAuthorship W4205697008A5027612655 @default.
- W4205697008 hasAuthorship W4205697008A5032927181 @default.
- W4205697008 hasAuthorship W4205697008A5036074880 @default.
- W4205697008 hasAuthorship W4205697008A5037009065 @default.
- W4205697008 hasAuthorship W4205697008A5043862869 @default.
- W4205697008 hasAuthorship W4205697008A5043877274 @default.
- W4205697008 hasAuthorship W4205697008A5045482135 @default.
- W4205697008 hasAuthorship W4205697008A5045557788 @default.
- W4205697008 hasAuthorship W4205697008A5049778403 @default.
- W4205697008 hasAuthorship W4205697008A5051165361 @default.
- W4205697008 hasAuthorship W4205697008A5053619220 @default.
- W4205697008 hasAuthorship W4205697008A5056005213 @default.
- W4205697008 hasAuthorship W4205697008A5056277307 @default.
- W4205697008 hasAuthorship W4205697008A5064965402 @default.
- W4205697008 hasAuthorship W4205697008A5073778883 @default.
- W4205697008 hasAuthorship W4205697008A5075358751 @default.
- W4205697008 hasAuthorship W4205697008A5088674785 @default.
- W4205697008 hasBestOaLocation W42056970081 @default.
- W4205697008 hasConcept C126322002 @default.
- W4205697008 hasConcept C134018914 @default.
- W4205697008 hasConcept C138411078 @default.
- W4205697008 hasConcept C177713679 @default.
- W4205697008 hasConcept C185592680 @default.
- W4205697008 hasConcept C195244886 @default.
- W4205697008 hasConcept C199289684 @default.